Nateglinide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nateglinide
HEALTH CANADA PATENTS

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Nateglinide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 10 USDMF, 2 CEP/COS, 4 JDMF, 4 EU WC, 7 NDC API, 5 Listed Suppliers, $ API Reference Price

14 API Suppliers
10 USDMF
2 CEP/COS
4 JDMF
4 EU WC
7 NDC API
5 Listed Suppliers
$ API Reference Price

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

45 FDF Dossiers, 18 FDA Orange Book, 8 Europe, 1 South Africa, 18 Listed Dossiers

45 FDF Dossiers
18 FDA Orange Book
8 Europe
1 South Africa
18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 4 DKSH, 3 Jai Radhe Sales, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 31 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

89 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 50 Direct Compression, 44 Disintegrants & Superdisintegrants, 33 Controlled & Modified Release, 31 Granulation, 26 Solubilizers, 25 Thickeners and Stabilizers, 22 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 18 Taste Masking, 15 Parenteral, 14 Film Formers & Plasticizers, 12 Topical, 7 API Stability Enhancers, 7 Emulsifying Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents

89 Fillers, Diluents & Binders
54 Coating Systems & Additives
50 Direct Compression
44 Disintegrants & Superdisintegrants
33 Controlled & Modified Release
31 Granulation
26 Solubilizers
25 Thickeners and Stabilizers
22 Lubricants & Glidants
19 Chewable & Orodispersible Aids
19 Co-Processed Excipients
18 Taste Masking
15 Parenteral
14 Film Formers & Plasticizers
12 Topical
7 API Stability Enhancers
7 Emulsifying Agents
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Rheology Modifiers
3 Surfactant & Foaming Agents

DIGITAL CONTENT

7 NEWS #PharmaBuzz

7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 JP, 6 Others

1 EDQM
1 USP
4 JP
6 Others

$ API Ref.Price (USD/KG) : 342 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Gowling Strathy & Henderson

filter Patent Reset all filters

6 All

01 32114678

02 32271865

filter Product Reset all filters

6 All

01 6Nateglinide

filter Dosage Reset all filters

6 All

01 6Tablet

filter Exp Date Reset all filters

6 All

01 32014-02-01

02 32017-11-14

Product Main Page

01

Gowling Strathy & Henderson

Nateglinide

Medlab Asia & Asia Health

Not Confirmed

Gowling Strathy & Henderson

Canada

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-11-14

Date Granted : 2003-10-14

Nateglinide

Brand Name : STARLIX

Patent Number : 2271865

Filing Date : 1997-11-14

Strength per Unit : 60mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-11-14

Date Granted : 2003-10-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Strathy & Henderson

Nateglinide

Medlab Asia & Asia Health

Not Confirmed

Gowling Strathy & Henderson

Canada

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-11-14

Date Granted : 2003-10-14

Nateglinide

Brand Name : STARLIX

Patent Number : 2271865

Filing Date : 1997-11-14

Strength per Unit : 120 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-11-14

Date Granted : 2003-10-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Strathy & Henderson

Nateglinide

Medlab Asia & Asia Health

Not Confirmed

Gowling Strathy & Henderson

Canada

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-11-14

Date Granted : 2003-10-14

Nateglinide

Brand Name : STARLIX

Patent Number : 2271865

Filing Date : 1997-11-14

Strength per Unit : 180 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-11-14

Date Granted : 2003-10-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Strathy & Henderson

Nateglinide

Medlab Asia & Asia Health

Not Confirmed

Gowling Strathy & Henderson

Canada

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-02-01

Date Granted : 1999-04-27

Nateglinide

Brand Name : STARLIX

Patent Number : 2114678

Filing Date : 1994-02-01

Strength per Unit : 60mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-02-01

Date Granted : 1999-04-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling Strathy & Henderson

Nateglinide

Medlab Asia & Asia Health

Not Confirmed

Gowling Strathy & Henderson

Canada

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-02-01

Date Granted : 1999-04-27

Nateglinide

Brand Name : STARLIX

Patent Number : 2114678

Filing Date : 1994-02-01

Strength per Unit : 120 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-02-01

Date Granted : 1999-04-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling Strathy & Henderson

Nateglinide

Medlab Asia & Asia Health

Not Confirmed

Gowling Strathy & Henderson

Canada

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-02-01

Date Granted : 1999-04-27

Nateglinide

Brand Name : STARLIX

Patent Number : 2114678

Filing Date : 1994-02-01

Strength per Unit : 180 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-02-01

Date Granted : 1999-04-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?